Navigation Links
Laureate Pharma Honored as Emerging Life Sciences Company of the Year
Date:11/20/2008

PRINCETON, N.J., Nov. 20 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has been named the "Emerging Life Science Company of the Year" by The Eastern Technology Council, the largest technology and life sciences trade association in the greater Philadelphia, PA region. The company was honored for its innovation in services, achievement of milestones and strength of its management team, at the ETC's annual Enterprise Awards Gala at Philadelphia's Kimmel Center on November 18th.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

Laureate is an established leader in the contract manufacture of clinical supply of biopharmaceutical products that target diseases including various types of cancer, autoimmune diseases, bone disorders and infectious diseases. Over the past few years Laureate has demonstrated strong growth, expanding its facility and manufacturing capacity as well as capabilities. Laureate has achieved several milestones during its impressive history, including commissioning a new pilot plant, and becoming EBITDA positive in 2007. In addition, the company has signed major biopharmaceutical development and manufacturing contracts and fill/finish agreements growing its market share and boosting its revenue.

"We are honored to receive this prestigious Enterprise award from Eastern Technology Council," said Robert Broeze, Ph.D., President and the Chief Executive Officer of Laureate Pharma. "This is a tribute to our leadership, and our talented and committed staff. It is a great recognition of our world-class operations and our strategy for business success. The award validates our commitment to the advancement in human health and our vision of partnering with our clients to improve the quality of all the lives we touch."

The Enterprise Awards is the Eastern Technology Council's annual celebration of regional life sciences and technology companies and their leaders. The Emerging Life Science Company Award honors a company that has at least four years of strong operating results and revenues less than $50 million. Key considerations for the award include product or service innovation, strategic decisions that led to growth in revenues and/or earnings, and demonstrated ability to raise capital and achieve profitability.

About Laureate Pharma, Inc.

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. For more information, contact Michael Cavanaugh, Vice President Sales, Marketing, and Business Development at (609) 919-3400, or info@laureatepharma.com or visit www.laureatepharma.com.


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
2. Laureate Announces Manufacturing Agreement with Tolerx
3. Laureate Pharma to Add More Manufacturing Capacity
4. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
5. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
6. Laureate Pharma Reports Record Growth for 2007
7. Laureate Pharma Appoints Gary Swan as Vice President of Operations
8. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
9. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
10. American Scientists Named as Laureates of the 2008 (24th) Japan Prize
11. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
Breaking Biology News(10 mins):